[Highlights from the American College of Cardiology Annual Scientific Session 2005: March 5-9, 2005, Orlando, Florida].
Cedos International, 23, rue Gourgas, 1205 Genève.
E
E
Schaerlig
D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D000077144:Clopidogrel; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D009765:Obesity / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D000077285:Rimonabant; D020521:Stroke / Q000517:prevention & control; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D008078:Cholesterol, LDL; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D011720:Pyrazoles; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D000077285:Rimonabant